Click on image to view larger version.

Figure 3 Extent of hyperenhancement and clinical risk factors for sudden death. Hyperenhancement was associated with an increased clinical risk of sudden death (A), even when patients with progressive disease were excluded (B), and appeared more marked in patients <40 years old, regardless of the presence of progressive disease (C, D).